Molbio Diagnostics IPO — Broker Reviews

Molbio Diagnostics has emerged as a leading player in innovative point-of-care diagnostics products based on modern technology, with a global presence in more than 100 countries. The company posted steady growth in revenue and profit for the reported periods and enjoys a near-monopoly in its offerings. Based on recent financials, the issue appears fully priced. Well-informed investors can park funds for the medium to long term.